Expression of Ku70 correlates with survival in carcinoma of the cervix by Wilson, C R et al.
DNA-dependent protein kinase (DNA-PK) is a serine threonine
kinase whose activity is dependent on DNA binding. It is
composed of a catalytic subunit, DNA-PKcs, and the regulatory
subunit Ku (Smith and Jackson, 1999). The latter is a heterodimer
composed of ~70 kDa (Ku70) and ~80kDa (Ku80) proteins. There
are a number of observations that suggest that DNA-PK has a
specific role in the repair of DNA double strand breaks.
Embryonic stem cells lacking Ku70 or Ku80 are hypersensitive to
ionizing radiation and are deficient in V(D)J recombination, a
process that requires specific formation and rejoining of double-
strand breaks (Gu et al, 1997; Nussenzweig et al, 1997). Also,
when Chinese hamster ovary xrs-6 cells lacking functional Ku80
are transfected with the human chromosomal fragment coding for
Ku80, V(D)J recombination and radiation sensitivity are restored
to normal levels (Peterson et al, 1995; Ross et al, 1995). Finally,
irradiation of MCF-7 or Hela cell lines in the presence of wort-
mannin (a phosphatidylinositol 3-kinase (PI3 kinase) inhibitor)
increases sensitivity to ionizing radiation 3–5 fold (Price and
Youmell, 1996). The latter finding has been attributed to the down-
regulation of DNA-PK activity by wortmannin (Boulton et al,
1996), and is thought to be due to the homology between DNA-
PKcs and PI3 kinase (Hartley et al, 1995; Poltoratsky et al, 1995;
Izzard et al, 1999). 
There is evidence that the intrinsic radiosensitivity of tumour
cells is a determinant of outcome following radiotherapy (West 
et al, 1997). This has led to interest in finding a method for
measuring tumour radiosensitivity that is applicable for wide-
spread clinical use. The immunohistochemical analysis of DNA
repair enzymes involved in the recognition or repair of radiation-
induced DNA damage may have potential as a predictive assay of
tumour radiosensitivity. In support of this, we have already shown
that the expression of the human endonuclease HAPI correlates
with the radiation sensitivity of human cervix tumours (Herring 
et al, 1998). In this study we have examined the possible role of
Ku protein in determining tumour radiosensitivity and response 
to radiotherapy. 
MATERIALS AND METHODS 
Immunohistochemistry of Ku70 and Ku80 
Formalin-fixed, paraffin embedded sections (4 µ m thick) were
dewaxed for 10 min in xylene and rehydrated by passage through a
graded ethanol series to tap water. Endogenous peroxidases were
blocked with 3% hydrogen peroxide in Tris buffered saline (TBS)
for 20 min. After washing in TBS for 5 min, the sections were
blocked for a further 30 min using 10% normal swine serum
(Dako) in TBS. Serum was removed by tapping and 100 µ 1 of
antibody or TBS for control sections was added. Anti-Ku70 and 
-Ku80 rabbit polyclonal antisera were raised against bacterially
expressed full length human Ku70 or Ku80. They were used as
1:500 and 1:1000 dilutions in TBS, respectively. After incubation
at 4˚C for 18 hours in TBS, the sections were washed 3 times in
TBS for 5 min and incubated at room temperature for 30 min with
100 µ 1 of biotinylated swine anti-rabbit IgG heavy chain and light
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chain antiserum (SARBO, Dako) at 1:400 in TBS. The sections
were then washed 3 times in TBS for 5 min and incubated for
30 min at room temperature with 100 µ 1 biotinylated peroxidase-
streptavidin complex (ABC, Dako). Following three 5 min washes
in TBS, the sections were stained for 5 min with 100 µ l DAB
(1 fast-DAB tablet (Sigma) dissolved in 20 ml TBS plus 10 µ l
30% H2O2). The DAB was removed and the sections washed in
running tap water for 10 min and counterstained in Gills 
haemotoxylin for 1 min and blue alkali for 1 min. The sections
were then dehydrated through the graded ethanol series to xylene
and mounted. 
Quantification of Ku70 and Ku80 expression in tumour
sections using light microscopy 
The number of cells in tumour samples stained positive for Ku70
and Ku80 was determined by scoring ten microscope fields of 100
tumour cells, without prior knowledge of radiosensitivity and
treatment outcome, and determining the percentage of cells posi-
tive for Ku70 and Ku80 expression. The values are expressed as
mean percentages of the 10 fields plus or minus the standard error
of the mean. 
Tumour radiosensitivity 
The study was performed following South Manchester Medical
Research Ethics Committee approval. The patient details, treat-
ment protocols and assay methods are described elsewhere (West
et al, 1997). Briefly, all patients had bulky advanced disease and
received radiotherapy with curative intent. Small volume disease
was treated with intracavitary low-dose rate caesium alone.
Remaining patients either received external beam irradiation
(16 2 Gy fractions in 3 weeks) followed by two intracavitary
caesium insertions or external beam over 4 weeks supplemented
by a single low-dose rate intracavitary insertion. Random cervical
punch biopsies were taken prior to initiation of treatment. Radio-
sensitivity was determined in vitro using a soft agar clonogenic
assay as sensitivity to a single dose of 2 Gy radiation (SF2).
Follow-up schedules of 3 monthly in the first 2 years, 4 monthly in
the third year and 6 monthly for the next 2 years were employed.
Local recurrence within the radiation field was confirmed histo-
logically and/or using radiological techniques. Disease-specific
survival was measured with minimum and median follow-up times
of 24 and 58 months, respectively. 
DATA ANALYSIS 
The SPSS statistical software program was used to test for correla-
tions between quantitative variables by the establishment of non-
parametric linear regression. The probabilities of overall survival
and local control was determined using univariable log-rank
analysis, with the variables grouped into two (above and below
median values) bands. As group boundaries correspond to medians,
values falling on the boundaries meant that, in practice, the data
subsets were not always exactly the same size. A significance level
of 0.05 was used throughout. 
RESULTS 
The specificity of the antibodies was investigated in western blots
of human whole cell extracts, where the Ku70 antibody recognized
a single 70 kDa protein, and the Ku80 antibody recognized a
single 80 kDa protein. Tris buffered saline (TBS) was used as a
negative control. No staining was seen in any of the sections when
TBS was used. Staining for Ku70 and Ku80 was predominantly
nuclear. 
To determine whether the scoring was reproducible, the 77
sections were scored blind twice and a t-test performed on the
data. There was no significant difference between the percentage
of cells stained positive for the proteins in the two data sets. Also
the repeat scoring results were highly correlated for both Ku70 
(r = 0.96, P < 0.001) and Ku80 (r = 0.98, P = 0.001). In order to
examine inter-observer reproducibility, 12 sections were scored
independently by another individual (CMLW). There was a signifi-
cant correlation between the percentage of cells scored positive 
for both Ku70 (r = 0.74, P = 0.006) and Ku80 (r = 0.62, 
P = 0.031). 
The percentage of cells expressing Ku70 and Ku80 in different
tumours ranged from 0–95% for both (Table 1). Several of the
sections exhibited pronounced intercellular variation in staining
for Ku70 and Ku80 and a similar pattern of staining for both Ku70
and Ku80 could be seen in the individual sections. There was a
high degree of correlation between the percentage of cells express-
ing Ku70 and Ku80 in the tumour sections and 11 of the 77 tumours
had a low number of cells expressing Ku proteins (Figure 1). For
some of the tumours data were available for mitotic (n = 37) and
Ki67 (n = 25) index. There were no correlations between tumour
Table 1 Biological parameters 
n Mean ± SD Median Range 
Ku70a 77 67 ± 22% 75% 0–95% 
Ku80a 77 69 ± 24% 77% 0–95% 
SF2b 53 0.45 ± 0.18 0.42 0.14–0.91 
aThe levels of Ku70 and Ku80 expression was determined by scoring ten
microscope fields of 100 tumour cells and determining the percentage of cells
positive for Ku70 and Ku80 expression. Values were expressed as mean
percentages of the 10 fields scored. The mean, median and range of the
mean values for the 77 tumours scored are given. bSF2 is surviving fraction
at 2 Gy, a measure of tumour radiosensitivity. 
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Figure 1 Ku70 and Ku80 expression in adjacent sections of 77 cervix
carcinomas. Data points represent the mean and the standard error of the
percentage of cells stained positive for Ku70 or Ku80 in 10 microscope fields
of 100 tumour cells proliferation and the expression of either Ku70 or Ku80 (P > 0.26
for all). 
SF2 values were available for 53 of the tumour samples (West et
al, 1997) and these ranged from 0.14 to 0.91 with a median value
of 0.42 (Table 1). There was a borderline significant correlation
between intrinsic sensitivity to ionizing radiation and Ku70
expression (r = 0.26, P = 0.057) but no relationship for Ku80 
(r = 0.18, P = 0.19). These relationships are illustrated in Figure 2
and show that tumours with high SF2 value (i.e., radioresistant
tumours with SF2 > 0.60) all had a high percentage of Ku positive
cells. 
Table 2 summarizes the distribution of patients regarding
disease stage, tumour grade and histology. The median age for the
77 patients was 55 years (range 29–79 years). Relationships were
examined between Ku expression and the clinical parameters
listed in Table 2. No significant relationships were seen. Log-rank
analysis was performed to determine whether Ku70 or Ku80
expression could be used as prognostic indicators for the response
of cervical carcinoma patients to radiotherapy (Figure 3). Survival
levels for patients with tumours with high versus low Ku70 were
47% and 69%, respectively (Table 3). The difference reached
statistical significance (P = 0.046). There was also a higher level
of survival for patients whose tumours had a below median
percentage of Ku80 positive cells (69%) as opposed to those with
higher than median level (50%), but the differences did not reach
statistical significance (P = 0.087). Similar relationships were seen
for local control but these also did not reach statistical significance
(Figure 4). Table 3 summarizes the outcome data for Ku70, Ku80,
SF2, age and stage for the patients included in the study. Although,
there were insufficient patient numbers for a multivariate analysis,
bivariable analyses were carried out. Borderline significant corre-
lations were seen after allowing for age and stage but the prog-
nostic significance of Ku expression was lost after allowing for
SF2. Also while there appeared to be no stage-dependent effect,
there was for age. Tumour Ku expression was not important for
young women, below the median age. However, for older women
there was a large difference in survival for both Ku70 (P = 0.040)
and Ku80 (P = 0.0034). 
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Figure 2 Relationship between SF2 and Ku70 (top) and Ku80 (bottom)
expression in 53 cervix carcinomas. Data points represent the mean with
standard errors of 10 microscope fields of 100 tumour cells (Ku expression)
or 4–8 replicate colony counts (SF2) 
Table 2 Ku70 and Ku80 expression in relation to clinical parameters 
n Ku70 (%) Ku80 (%) 
Stage I 15 67 73 
II 29 73 73 
III 33 76 81 
Grade WELL 14 70 74 
MOD 39 69 77 
POOR 8 69 78 
Histology SCC 61 69 76 
ADENO 11 64 68 
Age <55 yrs 32 76 78 
≥ 55 yrs 45 73 76 
Values are the mean of the mean percentage of cells in tumour samples
stained positive for the Ku proteins. 
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Figure 3 Survival following radiotherapy versus Ku70 (top) and Ku80
(bottom) expression. The data from 77 patients were stratified according to
the median of the mean number of cells in tumour samples stained positive
for the Ku proteins. Upper arms represent patients with low tumour
expression of Ku70 or Ku80. The number of deaths/total number of patients
per group is given on each arm Ku and radiosensitivity in cervical carcinoma 1705
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DISCUSSION 
Staining for Ku70 and Ku80 in all the cervix tumours studied was
predominantly nuclear as expected from previous reports using
direct immunofluorescence (Higashiura et al, 1992; Hong et al,
1994). There was a high degree of intratumour heterogeneity in Ku
expression. This is unlikely to result from heterogeneity in cell
cycle phase distribution for several reasons. First, Ku has been
shown to remain in the nucleus throughout the cell cycle (Yaneva
and Jhiang, 1991). Second, no correlation was seen between Ku70
or Ku80 expression and tumour proliferation measured as either
mitotic or Ki67 index. Also, there was a good correlation between
the number of cells in tumour samples stained positive for Ku70
and Ku80 that supports in vitro studies of the interdependence of
the two heterodimer components (Satoh et al, 1995). The latter
suggests that intratumour heterogeneity in Ku expression is not a
staining artefact. 
In a study from which the cohort of patients studied here was
taken, tumour SF2 has been shown to be a highly significant 
prognostic factor for cervical carcinoma undergoing radiotherapy
(West et al, 1997, 1998). SF2 is a measure of the intrinsic radiosen-
sitivity of cells. As described earlier, there is ample evidence for a
role of Ku in determining cellular response to radiation. However,
no significant correlation was found between SF2 and the expres-
sion of Ku70 or Ku80. A similar lack of correlation between SF2
and DNA-PK activity has been shown, albeit in cell lines derived
from 9 malignant gliomas (Allalunis-Turner et al, 1995). Others
have shown that, in comparison with radioresistant lines, some
radiosensitive tumour cell lines have less DNA-PK activity
(Polischouk et al, 1999; Sirzen et al, 1999). There has been one
other study using human tumours where SF2 has been measured as
described here (Bjork Eriksson et al, 1999). The latter study, on
head and neck tumours, also showed no significant correlation
between SF2 and either DNA-PKcs (r = 0.22, P = 0.081) or Ku
(p70/p80) (r = 0.064, P = 0.62) expression in 64 tumours.
However, in both the latter study and ours, tumours with a low
percentage of Ku or DNA-PKcs positive cells were all sensitive,
with low SF2 values. This suggests that loss of Ku expression may
account for the radiosensitivity of some tumours. However, the
radiosensitivity of tumours with a high percentage of Ku positive
cells may be due to the mutation or down-regulation of other
DNA-damage sensing or repair proteins. Alternatively/addition-
ally the lack of correlation seen may be because studies using
primary human tumours or early passage cell lines assessing radio-
sensitivity using clonogenic assays will analyse a sub-population
of cells whilst immunohistochemical staining/cell extract measure-
ments are performed on the total tumour population. There may
also be cell type-dependent differences. 
A link between Ku expression and ionizing radiation sensitivity
is further supported by the significantly higher survival for
patients whose tumours had a low percentage of Ku70 positive
cells (P = 0.046). The difference in patient outcome was also
reflected with Ku80, but did not reach significance (P = 0.086).
The poorer prognosis of patients with high Ku70 expression
suggests that tumour cells with the ability to repair damaged DNA
are more likely to survive and proliferate following treatment. 
Interest in measuring radiosensitivity lies not only in tumours
but also normal tissues (West et al, 1998). Therefore, it would be
useful to examine the relationship between tumour and normal
tissue expression levels of Ku proteins. No relationship was seen
between DNA-PK mRNA levels/activity in a group of human
fibroblast lines (Kasten et al, 1999). In addition, a recent study has
shown that acquired radioresistance in a murine cell line was asso-
ciated with an increase in Ku activity (Frit et al, 1999). It may be
that the high levels of Ku protein seen in most of the tumours
studied here are an acquired phenotype. In order to test this,
parallel samples of tumour and normal tissue should be taken from
patients. 
In conclusion, despite reports of changes in radiosensitivity
when Ku levels are markedly altered, no significant correlation
was seen between tumour Ku protein expression and in vitro
radiosensitivity. However, there was a wide variation in the degree
Table 3 Outcome data 
Parameter Stratification Survival Local control 
Ku70 <75% 69% 82% 
>75% 47% 0.046 71% 0.19
Ku80 <77% 69% 85% 
>77% 50% 0.087 69% 0.060
SF2 <0.42 78% 85% 
>0.42 36%  0.0009 68%  0.079
Stage I 93% 93% 
II 55% 76% 
III 45% 0.0036 70% 0.082
Age <55 yrs 50% 65% 
>55 yrs 64% 0.29 84% 0.067
Values in italics are P values from log-rank analyses. 
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Figure 4 Local control following radiotherapy versus Ku70 (top) and Ku80
(bottom) expression. The data from 77 patients were stratified according to
the median number of cells in tumour samples stained positive for the Ku
proteins. Upper arms represent patients with low tumour expression of Ku70
or Ku80. The number of deaths/total number of patients per group is given on
each arm1706 CR Wilson et al
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of antibody staining between tumours and all tumours with a low
percentage of Ku positive cells were radiosensitive. In addition,
we have shown that expression of Ku70 in human cervix carci-
noma is prognostic for survival for patients undergoing radio-
therapy. This finding suggests that DNA-PK is involved in
determining cancer outcome via its involvement in DNA dsb
repair but other factors are also important. It is likely that the most
accurate prediction of treatment outcome will lie in assessing the
expression of several proteins involved in the recognition and
repair of DNA damage, one of which will be Ku. 
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